What can we help you find?

Leading the way in transplantation

Filter results for:

Tremor and tacrolimus formulation

May 9, 2024 | All

In the latest issue of Transplant International, Magali Giral and colleagues studied the impact of switching from immediate- and prolonged-release tacrolimus to extended-release tacrolimus on tremor and quality of life in 221 kidney recipients. In this prospective, French multicentre study, the authors found a significant positive effect of the switch on tremor and SF-12 mental component score, and the physical component score and other neurological symptoms also tended to improve. The authors concluded that switching to extended-release tacrolimus was safe, increased the bioavailability of tacrolimus and concentration-to-dose ratio, and improved tremor and health-related quality of life.

Read the article here

 

Share this
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.